1. Home
  2. AVDL vs NNE Comparison

AVDL vs NNE Comparison

Compare AVDL & NNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • NNE
  • Stock Information
  • Founded
  • AVDL 2015
  • NNE 2022
  • Country
  • AVDL Ireland
  • NNE United States
  • Employees
  • AVDL N/A
  • NNE N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • NNE
  • Sector
  • AVDL Health Care
  • NNE
  • Exchange
  • AVDL Nasdaq
  • NNE NYSE
  • Market Cap
  • AVDL 784.6M
  • NNE 869.7M
  • IPO Year
  • AVDL 1996
  • NNE 2024
  • Fundamental
  • Price
  • AVDL $9.39
  • NNE $24.06
  • Analyst Decision
  • AVDL Strong Buy
  • NNE Strong Buy
  • Analyst Count
  • AVDL 7
  • NNE 2
  • Target Price
  • AVDL $18.86
  • NNE $58.00
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • NNE 1.4M
  • Earning Date
  • AVDL 05-07-2025
  • NNE 06-20-2025
  • Dividend Yield
  • AVDL N/A
  • NNE N/A
  • EPS Growth
  • AVDL N/A
  • NNE N/A
  • EPS
  • AVDL N/A
  • NNE N/A
  • Revenue
  • AVDL $194,450,000.00
  • NNE N/A
  • Revenue This Year
  • AVDL $50.53
  • NNE N/A
  • Revenue Next Year
  • AVDL $32.33
  • NNE N/A
  • P/E Ratio
  • AVDL N/A
  • NNE N/A
  • Revenue Growth
  • AVDL 252.64
  • NNE N/A
  • 52 Week Low
  • AVDL $6.38
  • NNE $3.25
  • 52 Week High
  • AVDL $17.85
  • NNE $48.05
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 64.66
  • NNE N/A
  • Support Level
  • AVDL $8.55
  • NNE N/A
  • Resistance Level
  • AVDL $9.98
  • NNE N/A
  • Average True Range (ATR)
  • AVDL 0.51
  • NNE 0.00
  • MACD
  • AVDL 0.10
  • NNE 0.00
  • Stochastic Oscillator
  • AVDL 72.04
  • NNE 0.00

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About NNE NANO NUCLEAR ENERGY INC

Nano Nuclear Energy Inc is an early-stage nuclear energy company developing smaller, cheaper, and safer portable clean energy solutions. It is focused on four business lines as part of development-Micro Nuclear Reactor Business is developing the next-generation nuclear microreactors, in particular ZEUS, a solid core battery reactor, and ODIN, a low-pressure salt coolant reactor; Fuel Processing Business; Fuel Fabrication Business; Fuel Transportation Business, and Nuclear Consultation Services.

Share on Social Networks: